[go: up one dir, main page]

EE200200209A - Otsese pressimisega valmistatud polümeerne tabletisüdamik - Google Patents

Otsese pressimisega valmistatud polümeerne tabletisüdamik

Info

Publication number
EE200200209A
EE200200209A EEP200200209A EEP200200209A EE200200209A EE 200200209 A EE200200209 A EE 200200209A EE P200200209 A EEP200200209 A EE P200200209A EE P200200209 A EEP200200209 A EE P200200209A EE 200200209 A EE200200209 A EE 200200209A
Authority
EE
Estonia
Prior art keywords
direct compression
tablet core
polymer tablet
compression polymer
core
Prior art date
Application number
EEP200200209A
Other languages
English (en)
Estonian (et)
Inventor
Tyler Joseph
S. Petersen John
Original Assignee
Geltex Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals, Inc. filed Critical Geltex Pharmaceuticals, Inc.
Publication of EE200200209A publication Critical patent/EE200200209A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200200209A 1999-10-19 2000-10-13 Otsese pressimisega valmistatud polümeerne tabletisüdamik EE200200209A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (en) 1999-10-19 2000-10-13 Direct compression polymer tablet core

Publications (1)

Publication Number Publication Date
EE200200209A true EE200200209A (et) 2003-06-16

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200209A EE200200209A (et) 1999-10-19 2000-10-13 Otsese pressimisega valmistatud polümeerne tabletisüdamik

Country Status (29)

Country Link
EP (1) EP1239837B1 (xx)
JP (4) JP4942271B2 (xx)
KR (1) KR100794427B1 (xx)
CN (1) CN1202812C (xx)
AR (1) AR026067A1 (xx)
AT (1) ATE286386T1 (xx)
AU (1) AU778262B2 (xx)
BG (1) BG106626A (xx)
BR (1) BRPI0015061B8 (xx)
CA (1) CA2387915C (xx)
CZ (1) CZ20021344A3 (xx)
DE (1) DE60017285T2 (xx)
EA (1) EA200200387A1 (xx)
EE (1) EE200200209A (xx)
ES (1) ES2235969T3 (xx)
HK (1) HK1049451B (xx)
HU (1) HUP0203334A2 (xx)
IL (1) IL149146A0 (xx)
IS (1) IS6343A (xx)
MX (1) MXPA02003684A (xx)
MY (1) MY125495A (xx)
NO (1) NO20021827L (xx)
NZ (1) NZ518334A (xx)
PL (1) PL364888A1 (xx)
PT (1) PT1239837E (xx)
SK (1) SK5412002A3 (xx)
TR (1) TR200201087T2 (xx)
TW (1) TWI225413B (xx)
WO (1) WO2001028527A2 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778262B2 (en) * 1999-10-19 2004-11-25 Genzyme Corporation Direct compression polymer tablet core
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
JP2007517047A (ja) * 2003-12-31 2007-06-28 ジェンザイム・コーポレーション 腸溶コーティングされた脂肪族アミンポリマーの胆汁酸捕捉因子
DE112005000725B4 (de) 2004-03-30 2017-12-21 Relypsa, Inc. (n.d.Ges.d. Staates Delaware) Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
AU2006227429A1 (en) * 2005-03-17 2006-09-28 Amgen Inc. Methods of decreasing calcification
JP2009507019A (ja) 2005-09-02 2009-02-19 ジェンザイム・コーポレーション リン酸塩を除去する方法およびそれに使用される重合体
KR101547925B1 (ko) * 2005-09-15 2015-08-27 젠자임 코포레이션 아민 중합체에 대한 샤셋 제형
BRPI0717008A2 (pt) * 2006-09-01 2014-01-21 Usv Ltd Processo para o preparo de cloridrato de sevelamer e formulação do mesmo
WO2008042222A2 (en) 2006-09-29 2008-04-10 Genzyme Corporation Amide dendrimer compositions
WO2008076242A1 (en) 2006-12-14 2008-06-26 Genzyme Corporation Amido-amine polymer compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) * 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
KR20110059750A (ko) 2008-09-02 2011-06-03 유에스브이 리미티드 가교 폴리머
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
WO2010149794A2 (en) 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
DK2490675T3 (en) * 2009-10-22 2019-04-29 Synthon Bv Pharmaceutical compositions with sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
US9693962B2 (en) * 2012-06-05 2017-07-04 Takeda Pharmaceutical Limited Dry-coated tablet
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5490987A (en) * 1991-07-03 1996-02-13 The Upjohn Company Tableting of colestipol hydrochloride
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
AU778262B2 (en) * 1999-10-19 2004-11-25 Genzyme Corporation Direct compression polymer tablet core

Also Published As

Publication number Publication date
JP2016000753A (ja) 2016-01-07
JP4942271B2 (ja) 2012-05-30
KR100794427B1 (ko) 2008-01-16
ES2235969T3 (es) 2005-07-16
WO2001028527A3 (en) 2002-01-03
DE60017285T2 (de) 2005-12-08
AU1088701A (en) 2001-04-30
IS6343A (is) 2002-04-15
AU778262B2 (en) 2004-11-25
BR0015061A (pt) 2002-07-23
MY125495A (en) 2006-08-30
ATE286386T1 (de) 2005-01-15
NO20021827L (no) 2002-05-29
JP2003512317A (ja) 2003-04-02
CN1202812C (zh) 2005-05-25
SK5412002A3 (en) 2002-09-10
EP1239837B1 (en) 2005-01-05
BG106626A (bg) 2003-03-31
BRPI0015061B1 (pt) 2016-03-22
AR026067A1 (es) 2002-12-26
JP5903111B2 (ja) 2016-04-13
NZ518334A (en) 2003-08-29
NO20021827D0 (no) 2002-04-18
HUP0203334A2 (hu) 2003-02-28
HK1049451A1 (en) 2003-05-16
EA200200387A1 (ru) 2002-10-31
WO2001028527A2 (en) 2001-04-26
PL364888A1 (en) 2004-12-27
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
IL149146A0 (en) 2002-11-10
CN1382041A (zh) 2002-11-27
PT1239837E (pt) 2005-05-31
BRPI0015061B8 (pt) 2021-05-25
HK1049451B (zh) 2005-12-16
EP1239837A2 (en) 2002-09-18
JP2012067132A (ja) 2012-04-05
JP2014065749A (ja) 2014-04-17
JP5583110B2 (ja) 2014-09-03
MXPA02003684A (es) 2002-08-30
KR20020059629A (ko) 2002-07-13
CA2387915A1 (en) 2001-04-26
DE60017285D1 (de) 2005-02-10
CA2387915C (en) 2007-04-17
CZ20021344A3 (cs) 2002-08-14

Similar Documents

Publication Publication Date Title
NO20021827D0 (no) Direkte kompresjons-polymer tablettkjerne
DE60042164D1 (de) Kompaktes nadelschutzschild
DE60042859D1 (de) Polymerisationsverfahren
DE60024345D1 (de) Polymerelektrolyt
NO2008005I1 (no) Trabectedin
DE60025897D1 (de) Polymerbindemittel
DE60026459D1 (de) Simethicon enthaltendes Abführmittel
DE60039789D1 (de) Polymerzelle
DE60017202D1 (de) Polymerisationsverfahren
FI991029L (fi) Puristin
DE50009614D1 (de) Pressenpartie
DE50003528D1 (de) Formkörper
NO991364D0 (no) Komprimeringsmaskin
DE69936634D1 (de) Medizinischer Kompressionsartikel
DE50013385D1 (de) Entgasungseinrichtung
DK1239837T3 (da) Polymertabletkerne fremstillet ved direkte kompression
DE60022732T2 (de) Audiokodierung
NO991359D0 (no) Tablettdispenser
ZA200202772B (en) Direct compression polymer tablet core.
DE50000416D1 (de) Totpunktschalter
FI4077U1 (fi) Pellettipuristin
FIU990201U0 (fi) Pakkausalusta
FI990823L (fi) Puristin
FI991250L (fi) Puristin
UA3100S (uk) Стійка під гантелі